Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Hypertension

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00004872-200112000-00011PMID 11725162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary N-Acetyl-P-D-Glucosaminidase Changes in Relation to Age, Sex, Race, and Diastolic and Systolic Blood Pressure in a Young Adult Biracial Population

  2003cited by this paper
• Cardiostimulant effects of urotensin‐II in human heart in vitro

  2001cited by this paper
• Antiangiogenesis signals by endostatin.

  2001cited by this paper
• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000cited by this paper
• Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway.

  2000cited by this paper
• Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology

  2000cited by this paper
• Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

  2000cited by this paper
• Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1

  2000cited by this paper
• Human urotensin‐II is a potent spasmogen of primate airway smooth muscle

  2000cited by this paper
• Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteries

  2000cited by this paper
• Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

  1999cited by this paper
• LightCycler technology for the quantitation of bcr/abl fusion transcripts.

  1999cited by this paper
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis.

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Secretion of Adrenomedullin by Renal Tubular Cell Lines

  1997cited by this paper
• Product differentiation by analysis of DNA melting curves during the polymerase chain reaction.

  1997cited by this paper
• The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.

  1997cited by this paper
• Urinary N-Acetyl-β-D-Glucosaminidase Changes in Relation to Age, Sex, Race, and Diastolic and Systolic Blood Pressure in a Young Adult Biracial Population the Bogalusa Heart Study

  1996cited by this paper
• Urinary N-acetyl-beta-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. The Bogalusa Heart Study.

  1996cited by this paper
• Characterization of immunoreactive adrenomedullin in human plasma and urine.

  1995cited by this paper
• Urinary excretion of endothelin-1 in normal subjects and patients with renal disease.

  1991cited by this paper
• Presence of immunoreactive endothelin in human plasma

  1989cited by this paper
• A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine.

  1986cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper

• Role of Rs228648 and Rs2890565 single nucleotide polymorphisms in Urotensin-2 gene in prostate cancer

  2025cites this paper
• Urotensin II system in chronic kidney disease

  2024cites this paper
• Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats

  2023cites this paper
• 2-{N-[(2,4,5-trichlorophenoxy) acetyl]-N-methylamino}-3-pyrrolidinepropanamide analogs as potential antagonists of Urotensin II receptor

  2023cites this paper
• Expression of Urotensin II of Human Placental Tissues and in Serum in Gestational Diabetic Mellitus in Iraqi Woman

  2022cites this paper
• Urotensin-2 Receptor Antagonist - Palosuran Decreases Blood Pressure And Plasma Renin Concentration In Laboratory Rats With Renovascular Hypertension

  2021cites this paper
• Characterization of Four Urotensin II Receptors (UTS2Rs) in Chickens.

  2020cites this paper
• Effects of Alpha-Lipoic Acid on TGF-β1 and Urotensin-II Levels in Glucocorticoid-Induced Osteonecrosis in Rats

  2020cites this paper
• Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.

  2020cites this paper
• Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study

  2020cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

  2019cites this paper
• The association of urotensin II with arterial stiffness and atherosclerosis in patients with autosomal dominant polycystic kidney disease

  2019cites this paper
• Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat

  2019cites this paper
• Plasma urotensin-2 as a marker for menstrual irregularities in women: a clinical study

  2019cites this paper
• Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.

  2019cites this paper
• Synthesis and SAR of 5-aryl-furan-2-carboxamide derivatives as potent urotensin-II receptor antagonists.

  2019cites this paper
• Urotensin II: an inflammatory cytokine.

  2019cites this paper
• Genetic polymorphisms of UTS2 rs2890565 Ser89Asn in coronary heart disease and myocardial infarction in Chinese population.

  2018cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• 14.11 – Vasoactive Substances as Mediators of Renal Injury

  2018cites this paper
• The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus

  2018cites this paper
• Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects

  2018cites this paper
• Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia

  2018cites this paper
• The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features

  2017cites this paper
• Synthèse en phase solide de pyrrolo[3,2-e][1,4]diazépin-2-ones modulateurs du système urotensinergétique

  2017cites this paper
• Indole‐2‐carboxamide Derivatives as Potent Urotensin‐II Receptor (UT) Antagonists

  2017cites this paper
• serum Evaluation of serum urotensin-II levels of children with ADHD and autism spectrum disorder

  2017cites this paper
• Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

  2017cites this paper
• Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis

  2017cites this paper
• Opposite actions of urotensin II and relaxin‐2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study

  2017cites this paper
• Urotensinergic system genes in experimental subarachnoid hemorrhage.

  2017cites this paper
• Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study

  2017cites this paper
• [Changes in serum chromogranin A and urotensin II levels in children with chronic heart failure].

  2017cites this paper
• Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout.

  2016cites this paper
• Genetic polymorphisms of UTS2 rs2890565 Ser89Asn in cardiac hypertrophy in Chinese Han population

  2016cites this paper
• Structure–Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9

  2016cites this paper
• Homology Modelling of Urotension-2 Receptor (UTS2R): Potential Target for Human Pharmacotherapy

  2016cites this paper
• vasoconstrictionangiotensin II and in urotensin II-induced Role of PKC in the novel synergistic action of urotensin II

  2016cites this paper
• Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists.

  2016cites this paper
• Role of UTS2 gene in the genetic susceptibility to atrial fibrillation in the Chinese population

  2016cites this paper
• Expression levels of urotensin II are associated with endoplasmic reticulum stress in patients with severe preeclampsia

  2016cites this paper
• Role of urotensin II in advanced glycation end product-induced extracellular matrix synthesis in rat proximal tubular epithelial cells.

  2016cites this paper
• Oxidative Stress and Essential Hypertension

  2016cites this paper
• An investigation into the expression and mechanism of action of urotensin II in chronic pressure-overloaded rat hearts

  2015cites this paper
• Association between essential hypertension and three vasoactive peptides, urotensin II, endothelin and adrenomedullin

  2015cites this paper
• Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

  2015cites this paper
• NMR spectroscopy: a useful tool for drugs development and monitoring biological reactions

  2015cites this paper
• Oxidative stress in hypertension: mechanisms and therapeutic opportunities.

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015influential citation
• 1,3,4‐Thiadiazol‐2‐amine Derivatives as Urotensin‐II Receptor (UT) Antagonists

  2015cites this paper
• Blocking the urotensin II receptor pathway ameliorates the metabolic syndrome and improves cardiac function in obese mice

  2014cites this paper
• 2: Dyslipidemia and Atherosclerosis

  2014cites this paper
• Papel del estrés oxidativo en la patogénesis de la hipertensión arterial

  2014cites this paper
• Molecular evolution of GPCRs: Somatostatin/urotensin II receptors.

  2014cites this paper
• Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats

  2014cites this paper
• Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.

  2014cites this paper
• Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists.

  2014cites this paper
• Role of oxidative stress in the pathogenesis of hypertension

  2014cites this paper
• Essential hypertension and oxidative stress: New insights.

  2014cites this paper
• HUMAN PRIMARY ALDOSTERONISM : FROM CLINICAL OBSERVATIONS TO IN-VIVO AND EX-VIVO STUDIES ON THE PRESSOR EFFECTS OF UROTENSIN II

  2013cites this paper
• Urotensin-II System in Genetic Control of Blood Pressure and Renal Function

  2013cites this paper
• Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures

  2013cites this paper
• Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions

  2013cites this paper
• Potential new treatments for diabetic kidney disease.

  2013cites this paper
• Analysis of genetic variation within urotensin-II system in regulation of blood pressure and renal function

  2013influential citation
• Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis.

  2013cites this paper
• Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.

  2013cites this paper
• Clinical & Neurohormonal Predictors of Outcome after Electrical Cardioversion for Atrial Fibrillation

  2013cites this paper
• Pressor and renal regional hemodynamic effects of urotensin II in neonatal pigs

  2013cites this paper
• The Urotensin System Is Up-Regulated in the Pre-Hypertensive Spontaneously Hypertensive Rat

  2013cites this paper
• Urotensin II and the kidney

  2013influential citation
• New Therapeutics in Hypertension

  2012cites this paper
• Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation.

  2012cites this paper
• Vasoactive Molecules and the Kidney

  2012cites this paper
• Ontogeny of the renal urotensin II system in the rat

  2012influential citation
• Effects of urotensin II on functional activity of late endothelial progenitor cells.

  2012cites this paper
• Urotensin-II: More Than a Mediator for Kidney

  2012cites this paper
• A closer look at the role of urotensin II in the metabolic syndrome

  2012influential citation
• Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice

  2012cites this paper
• The role of oxidative stress in the pathophysiology of hypertension

  2011cites this paper
• Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver.

  2011cites this paper
• EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy

  2011cites this paper
• Urotensin II Levels Are an Important Marker for the Severity of Portal Hypertension in Children

  2011cites this paper
• The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.

  2011cites this paper
• Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells.

  2011cites this paper
• Increased urotensin‐II activity in patients with Raynaud’s phenomenon and systemic lupus erythematosus

  2011cites this paper
• Vasoactive Factors and Blood Pressure in Children

  2011cites this paper
• In Vitro Manipulation of Urotensin-II Receptor Expression: Implications of Receptor Density on Ligand Efficacy

  2011cites this paper
• Renal impairment, hypertension and plasma urotensin II.

  2011influential citation
• Potential Clinical Implications of the Urotensin II Receptor Antagonists

  2011influential citation
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy

  2010cites this paper
• Vasoactive Substances As Mediators of Renal Injury

  2010cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Urotensin-Peptiden

  2010cites this paper
• Urotensin II, from fish to human

  2010cites this paper
• Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.

  2010cites this paper
• The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways.

  2010cites this paper
• Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta.

  2010cites this paper
• rotein expression of urotensin II , urotensin-related peptide and their eceptor in the lungs of patients with lymphangioleiomyomatosis

  2010cites this paper